Alopexx
PrivateLast Round
IPO
Jun 26, 2026
Est. Valuation
$102M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Alopexx is a clinical-stage biotechnology company developing novel, broad-spectrum immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alopexx Comparables
Compare Alopexx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trellis Bioscience | 77% | |
| Bioversys | 76% | |
| Aridis Pharmaceuticals, Inc. | 75% |
Alopexx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 26, 2026 | ||||
| Strategic | Sep 10, 2024 | ||||
| Strategic | Sep 6, 2024 |
Alopexx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bharat Biotech | Strategic |
| ThinkEquity | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
$33M raised, led by ThinkEquity.
- Sep 10, 2024
Bharat Biotech participated in the strategic round.
Alopexx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alopexx's valuation, stock price, and market status.
Is Alopexx a public or private company?
Alopexx is a private company.
What is the current stock price of Alopexx?
Alopexx is a private company with no public stock price. Caplight tracks Alopexx's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Alopexx worth (valuation)?
Alopexx's valuation is estimated at $102.0M based on funding round data.
Can I buy Alopexx stock?
Alopexx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Alopexx's last funding round?
Alopexx's most recent funding round was IPO on June 26, 2026.
Who are the main investors in Alopexx?
Key investors in Alopexx include ThinkEquity.
Will Alopexx IPO soon?
No public IPO plans have been announced for Alopexx.
How can I track Alopexx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alopexx's secondary market activity and sign up for updates.